Back

Recurrent respiratory viral diseases and chronic sequelae due to dominant negative IFIH1

Deal, C. L.; Thauland, T. J.; Signer, R.; Nelson, S. F.; Undiagnosed Diseases Network, ; Lee, H.; Butte, M. J.

2020-07-06 allergy and immunology
10.1101/2020.07.01.20105379
Show abstract

Viral respiratory infections are the most common childhood infection worldwide. However, even common pathogens can have significant consequences in the context of patients with primary immunodeficiency diseases. More than half or viral infections annually are due to rhinovirus/enterovirus strains. Most clinical manifestations of viral infection are mild. However 3% of cases result in hospitalization in patients who have no other known risk factors. These patients may have an inborn error of immunity, a genetic susceptibility to viral infections. Here we present the case of an adult male who suffered respiratory viral infections his whole life and developed chronic, inflammatory damage to sinuses and lungs as a consequence. Genomic sequencing identified compound heterozygous variants in the IFIH1 gene, encoding the protein Melanoma Differentiation Association Protein 5 (MDA5), a RIG-I-like cytoplasmic sensor of RNA intracellular infections. We show a dominant negative effect on these variants on the level of interferon-induced expression of MDA5 protein. This work supports that loss-of-function variants in IFIH1 affect the sensing of viral infections. Underlying genomic variants may dictate the point at which recurrent, respiratory viral infections leave commonplace experience and incur lasting damage.

Matching journals

The top 7 journals account for 50% of the predicted probability mass.

1
PLOS ONE
based on 1737 papers
Top 39%
12.8%
2
Journal of Experimental Medicine
based on 10 papers
Top 0.1%
10.4%
3
Nature Communications
based on 483 papers
Top 12%
6.5%
4
Clinical Infectious Diseases
based on 219 papers
Top 4%
6.5%
5
Scientific Reports
based on 701 papers
Top 35%
5.2%
6
Journal of Clinical Immunology
based on 11 papers
Top 0.1%
4.8%
7
Nature Immunology
based on 14 papers
Top 0.2%
4.6%
50% of probability mass above
8
Clinical Immunology
based on 12 papers
Top 0.2%
3.0%
9
Allergy
based on 13 papers
Top 0.7%
2.9%
10
The Journal of Immunology
based on 19 papers
Top 0.5%
2.9%
11
Journal of Medical Virology
based on 95 papers
Top 4%
2.3%
12
Science Immunology
based on 15 papers
Top 0.6%
1.6%
13
eLife
based on 262 papers
Top 17%
1.6%
14
The American Journal of Human Genetics
based on 77 papers
Top 5%
1.6%
15
Frontiers in Immunology
based on 140 papers
Top 5%
1.4%
16
European Respiratory Journal
based on 44 papers
Top 4%
1.4%
17
Annals of the Rheumatic Diseases
based on 23 papers
Top 0.9%
1.4%
18
Nature Medicine
based on 88 papers
Top 10%
1.4%
19
Communications Biology
based on 36 papers
Top 2%
1.4%
20
Cell Reports Medicine
based on 49 papers
Top 4%
1.2%
21
Journal of Clinical Investigation
based on 50 papers
Top 3%
1.2%
22
JCI Insight
based on 63 papers
Top 5%
1.2%
23
EBioMedicine
based on 21 papers
Top 0.9%
1.2%
24
Cell
based on 28 papers
Top 2%
0.8%
25
Cell Genomics
based on 34 papers
Top 4%
0.8%
26
iScience
based on 74 papers
Top 7%
0.8%
27
mSphere
based on 27 papers
Top 3%
0.7%
28
Journal of Allergy and Clinical Immunology
based on 15 papers
Top 2%
0.7%
29
The Journal of Infectious Diseases
based on 137 papers
Top 11%
0.7%
30
Cells
based on 14 papers
Top 2%
0.7%